Features

4
MAR 2026

(WED)

CPD Seminar
The Microscopic World: Unlocking the Morphological Code of Plasmodium
6:30 PM – 7:30 PM
Room 3505, 3/F, Li Dak Sum Yip Yio Chin Academic Building
Mr Antonio Ngan,
Hospital Authority
7
AUG 2026

(FRI)

CPD Seminar
MALDI TOF MS in Clinical Microbiology: From Routine Identification to Emerging Applications
6:30 PM – 7:30 PM
Herbalgy Lecture Theatre (LT401), Bank of China (BOC) Complex
Mr Joy Pan,
Autobio Diagnostics,
China
11
NOV 2026

(WED)

Symposium
Mini Symposium on Molecular Diagnosis and Genomic Medicine
3:30–6:00 PM
John Chan Lecture Theatre (LT-11),
4/F Yeung Kin Man Academic Building, CityUHK
Co-organised by Department of Biomedical Sciences and Institute of Digital Medicine, City University of Hong Kong
Seminar
Current Trends in Digital Pathology & Future Directions
Speakers:
Dr Mak Siu Ming Mak, Hospital Authority
Prof. Hei Ming Lai, The Chinese University of Hong Kong
Mr Kun Gui, KFBio, China
20 September 2025 (Saturday)
9:00 am – 12:30 pm
Chan Kei Biu Lecture Theatre (LT-6),
4/F, Yeung Kin Man Academic Building
Current Trends in Digital Pathology & Future Directions
University Event
CityUHK Undergraduate
Info Day 2026
3 October 2026 (Saturday)
9:00 am
CityUHK Campus

An Introduction to Undergraduate Programmes in Department of Biomedical Sciences (JS1300, JS1805, JS1806, JS1807)

10:30 – 11:15 AM

YEUNG LT-6

Becoming a Biomedical Scientist – Exploring our Clinical Laboratories and Research Facilities
(JS1300, JS1805, JS1806, JS1807)

11:30 AM – 12:15 PM

Gather at YEUNG P4701

An Introduction to Undergraduate Programmes in Department of Biomedical Sciences (JS1300, JS1805, JS1806, JS1807)

2:30 – 3:15 PM

YEUNG LT-6

Becoming a Biomedical Scientist – Exploring our Clinical Laboratories and Research Facilities
(JS1300, JS1805, JS1806, JS1807)

3:30 – 4:15 PM

Gather at YEUNG P4701

CityUHK Undergraduate Info Day 2026
CityUHK researchers reveal how fructose can suppress liver cancer, opening a new therapeutic avenue
CityUHK researchers reveal how fructose can suppress liver cancer, opening a new therapeutic avenue

26 October 2026

Prof. Huiyong Yin (BMS) and Prof. Shanshan Zhong (TBSC) at CityUHK uncover how fructose suppresses liver cancer under specific metabolic conditions, identifying a promising therapeutic target and potential treatment using ebselen.

learn more
Prof. Zongli Zheng Received CityUHK Presidential Research Excellence Award
Prof. Zongli Zheng Received CityUHK Presidential Research Excellence Award

13 October 2026

On 2 October 2026, Prof. Zongli Zheng from CityUHK BMS received the Presidential Research Excellence Award for Junior Faculty, recognising his outstanding contributions to genomic medicine and precision genome editing.

learn more
Research led by Prof. Ming Chan reveals modulating chromatin dynamics of H2B mutations, shedding light on novel targeted therapy of breast cancer
Research led by Prof. Ming Chan reveals modulating chromatin dynamics of H2B mutations, shedding light on novel targeted therapy of breast cancer

12 October 2026

A research team led by Prof. Kui-ming Chan from CityUHK BMS discovered that H2BE113K, a missense H2B mutation, promotes colony formation and lung metastasis of breast cancer. The research revealed that H2BE113K plays a critical role in chromatin regulation, cellular function and breast cancer progression, shedding light on novel targeted therapy of breast cancer.

learn more
BMS Hosts Interactive Biomedical Workshops for Secondary School Students
BMS Hosts Interactive Biomedical Workshops for Secondary School Students

19 August 2026

BMS recently hosted two educational engagement events led by Dr HAN Kam Chu, Senior Teaching Fellow, introducing secondary school students to the principles of clinical diagnostics and biomedical research through interactive learning experiences.

learn more
Summer Workshop for Harbin Institute of Technology
Summer Workshop for Harbin Institute of Technology

19 August 2026

CityUHK BMS hosted a summer workshop for 20 students and a faculty representative from the School of Life Science and Technology at Harbin Institute of Technology (HIT), a member of China’s C9 League and one of the country’s “985” universities.

learn more
Study Tour to Sysmex Corporation in Kobe, Japan
Study Tour to Sysmex Corporation in Kobe, Japan

17 August 2026

15 final-year BScBMS students from CityUHK travelled to Kobe, Japan in April 2026 for a study tour of the global headquarters of Sysmex Corporation, a leading developer of diagnostic technologies.

learn more

Our
Pro­grammes

Explore our range of undergraduate and postgraduate programmes – with the high calibre of teaching, cutting-edge facilities and practical experiences – that best equip graudates for furture careers in healthcare, pharmaceutical, biotech and biomedical-related industries.

Recent
Research
Papers

Browse through some of our latest journal entries featuring extensive research carried out by our faculty, researchers and students.
H2BE113K mutation promotes breast cancer metastasis through modulating chromatin dynamics

S. Hu, J. Liu, J. Zhou, J. Chen, T. Qin, Y. C. E. Wan, X. Zhu, D. Wang, C. Shao, Y. Chen, X. Wang, J. Han, H. L. X. Wong, R. S. Weiss, H. Jin, M. Chen, Q. Li, Y. Saunthararajah, H. Gan, K. M. Chan (2026). H2BE113K mutation promotes breast cancer metastasis through modulating chromatin dynamics. Science Advances, 12(28):eadx4982.

NuRD-enabled CTCF-TET crosstalk orchestrates epigenome reprogramming and genome architecture

W. Sun, N. Wu, M. Xia, Y. Pan, M. Liu, S. Fan, J. Wang, Y. Zeng, L. Fan, J. Chen, G. Liu, H. Yan, Y. Qiu, Y. Xie, Z. Jiang, F. Chen, Y. Yin, J. Zhang, L. Li, W. Xie, H. Wang, L. Zhang, M. Yu, X. Wang, J. Yan (2026). NuRD-enabled CTCF-TET crosstalk orchestrates epigenome reprogramming and genome architecture. Molecular Cell, 86(13):2617-2634.e11.

Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis

Y. Wang, X. Zhang, N. Wang, H. Jiang, N. Liang, C. Du, C. Yin, R. Li, L. Zhang, Q. Tu, J. Lv, H. Ma, X. Xu, X. Kong, X. Chen, G. Liu, S. Chen, H. Xu, J. Qin, S. Li, Y. Tao, S. Zeng, H. Shen, M. D. Goncalves, S. Zhong, H. Yin (2026). Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis. Signal Transduction and Targeted Therapy, 11:195.

ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury

X. Chen, X. Yu, S. Zhong, P. Sha, R. Li, X. Xu, N. Liang, L. Zhang, L. Li, J. Zhang, M. Zhou, T. Lv, H. Ma, Y. Wang, Y. Ye, C. Yin, S. Chen, J. Tian, A. Sun, W. Wang, D. Yan, H.-T. Yang, H. Huang, P. Li, H. Yin (2026). ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury Circulation, 153(3):164–184.

aaaaatitlehere

* (bbbbbyear). aaaaatitlehere. cccccnameofjournalhere, dddddvolumehere(eeeeeissuehere):fffffpagenumberhere.

BMS Research
Thoughts

A Single Histone Mutation Fuels Breast Cancer Spread

Discovery reveals a potential new target for precision breast cancer therapy

Dietary Fructose Reveals New Vulnerability in Liver Cancer

Discovery of a metabolic mechanism that restrains tumour growth paves the way for precision therapies

A Genetic Twist That Makes Heart Attacks More Dangerous

ALDH2*2 Promotes Ferroptosis by Reprogramming Protein Translation

GenomePAM Breakthrough in CRISPR Gene Editing

New method speeds discovery of more precise tools for therapies

Coronavirus Hijacks Host Immunity via PIM1

Key Findings Open Path to Broad-Spectrum Antivirals

Get in
Touch

Address

Department of
Biomedical Sciences
City University of
Hong Kong

1A-101, 1/F, Block 1,
To Yuen Building,
31 To Yuen Street,
Kowloon Tong,
Hong Kong

29 October 2026